X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Therapeutic Advances in Chronic Disease

期刊標題檢索 THER ADV CHRONI 最新評論: It has been 20 days since submission, and we are still inviting revie... (2024-05-19)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Therapeutic Advances in Chronic Disease]您好,您是該頁面的第 19346 位訪客。

期刊簡介
期刊名稱Therapeutic Advances in Chronic Disease Therapeutic Advances in Chronic Disease
LetPub Score
7.3
50 ratings
Rate

Reputation
8.8

Influence
6.2

Speed
7.1

期刊簡稱THER ADV CHRONIC DIS
ISSN2040-6223
E-ISSN2040-6231
h-index28
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.201.0310.857
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Medicine (miscellaneous)
Q181 / 398

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Therapeutic Advances in Chronic Disease publishes the highest quality peer-reviewed research, reviews and scholarly comment in the drug treatment of all chronic diseases. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers involved in the medical treatment of chronic disease, providing a forum in print and online for publishing the highest quality articles in this area.
官方網站https://journals.sagepub.com/home/taj
在線稿件提交https://uk.sagepub.com/en-gb/asi/journal/therapeutic-advances-chronic-disease#submission-guidelines
開放訪問No
出版商SAGE Publications Inc.
主題領域Medicine
出版國/地區United States
發行頻率
創刊年0
每年文章數79每年文章數趨勢
黃金OA百分比89.87%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ2118/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2040-6223%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 12 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Therapeutic Advances in Chronic Disease】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature Biomedical EngineeringH-index: 9

    CiteScore: 45.30
    Biomaterials ResearchH-index: 0

    CiteScore: 10.20
    Systematic ReviewsH-index: 0

    CiteScore: 8.30
    Communications BiologyH-index: 0

    CiteScore: 8.60
    BME FrontiersH-index: 0

    CiteScore: 7.10
    Current Opinion in Biomedical EngineeringH-index: 0

    CiteScore: 8.60
    Tissue Engineering and Regenerative MedicineH-index: 15

    CiteScore: 6.80
    Intelligent MedicineH-index: 0

    CiteScore: 5.20
    Frontiers in Digital HealthH-index: 0

    CiteScore: 4.20
    Journal of Personalized MedicineH-index: 0

    CiteScore: 4.10
    學科內最受檢索的期刊 頁面查看次數
    Communications Biology217204
    Nature Biomedical Engineering116522
    Journal of Personalized Medicine32171
    Biomaterials Research28099
    Tissue Engineering Part C-Methods17858
    Systematic Reviews16772
    Tissue Engineering and Regenerative Medicine15917
    BMJ Supportive & Palliative Care9650
    BME Frontiers8300
    Tissue Engineering Part C-Methods7432
  •  

    Therapeutic Advances in Chronic Disease Therapeutic Advances in Chronic Disease
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [Therapeutic Advances in Chronic Disease] 的評論撰寫評論
作者: nWUBCYC


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-19 13:21:55 評論於
It has been 20 days since submission, and we are still inviting reviewers
(0) 讚! | nWUBCYC

作者: 筱萌公子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-13 19:53:14 評論於
I have been waiting for 3 months and still haven't received any invitations for reviewers. I feel anxious every day
(0) 讚! | 筱萌公子

作者: 筱萌公子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-13 15:28:54 評論於
It's been three months for me too, still inviting reviewers. When will this be postponed to?
(0) 讚! | 筱萌公子

作者: 龙爪幼怡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-10 18:34:09 評論於
Submission acceptance rate: 50.0%. Experience sharing: The speed is acceptable, peer review is standardized and rigorous, but the editorial attitude is good, and the manuscript review is serious. I look forward to this magazine
(0) 讚! | 龙爪幼怡

作者: 京城香萱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-09 16:39:46 評論於
Review Speed: 3.0 | Submission Matching Rate: 50.0 Experience Sharing: The speed is still ok, peer review is standardized and strict, but the editor's attitude is good, the review is serious, and I like this journal
(0) 讚! | 京城香萱

作者: 香风易绿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-06 15:40:17 評論於
Submitted an article, underwent external review for a couple of months, made revisions and got accepted. It took 2 more months from submission to acceptance, and everything went quite smoothly!
(0) 讚! | 香风易绿

作者: Harriet Nichols


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-04 23:04:21 評論於
Review speed: 3.0 | Submission acceptance rate: 25.0
Experience sharing: Maybe my article quality is not high enough, it will keep dragging on, can't find a reviewer, I waited for 3 months, and was rejected for not finding a reviewer
(0) 讚! | Harriet Nichols

作者: Jesse MacAdam


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-02 08:16:59 評論於
First review and revision took one and a half months, until the final confirmation and acceptance, a total of 3 months, very smooth. This journal is quite good and worth considering!
(0) 讚! | Jesse MacAdam

作者: 北陆斐斐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-01 20:18:10 評論於
The first review and revision process took about one and a half months, until receiving the acceptance letter. In total, it took four months for the whole process, which I consider to be quite fast. I wonder if you would also consider this speed to be quick? However, regardless, I still find this journal to be excellent. My article being accepted may be due to my excellent writing, or perhaps because the journal's review standards are very strict. Haha, either way, I think this journal is a worthy choice
(0) 讚! | 北陆斐斐

作者: 是志丹吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-29 22:50:10 評論於
This is quite fast!! Maybe the reason is that the quality of your article is relatively good. Generally speaking, the quality of the article is far higher than the average level of the journal, and the editorial department will accelerate the review process and rush to publish
(0) 讚! | 是志丹吖

作者: 是志丹吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-29 22:12:20 評論於
It is difficult to find reviewers for small journals
(0) 讚! | 是志丹吖

作者: 是志丹吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-29 19:12:12 評論於
The main reason is the difficulty in finding reviewers
(0) 讚! | 是志丹吖

作者: 紫霞红会


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-28 12:02:34 評論於
Review speed: 1.0 | Submission acceptance rate: 50.0
Experience sharing: Minor revisions accepted within two months, very efficient
(0) 讚! | 紫霞红会

作者: Harriet Nichols


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-25 18:14:25 評論於
How is your progress going now?
(0) 讚! | Harriet Nichols

作者: Harriet Nichols


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-24 19:54:11 評論於
The manuscript submitted on July 21 is still under editing. Why is it taking so long? Can someone tell me?
(0) 讚! | Harriet Nichols

作者: 留云旭明


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-23 16:57:35 評論於
Not recommended to invest, too slow
(0) 讚! | 留云旭明

作者: 留云旭明


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-23 16:48:32 評論於
Very slow
(0) 讚! | 留云旭明

作者: 碧桃晶辉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-04 12:46:37 評論於
How long until publication?
(0) 讚! | 碧桃晶辉

作者: 努力啊大天真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-21 22:59:11 評論於
May I ask about the progress now?
(0) 讚! | 努力啊大天真

作者: 努力啊大天真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-21 10:35:49 評論於
How about the comments from the reviewer? Was it accepted?
(0) 讚! | 努力啊大天真

作者: Nora Wilhelmina


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-17 14:30:13 評論於
Research focus: cardiovascular
Experience sharing: I submitted for a month, but still haven't found a reviewer. It's really frustrating
(0) 讚! | Nora Wilhelmina

作者: 留云旭明


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-14 15:43:27 評論於
This is already the 5th reviewer
(0) 讚! | 留云旭明

作者: 南风鹏飞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-29 17:36:38 評論於
How can there be such a high accuracy rate?
(0) 讚! | 南风鹏飞

作者: Cornelius Lynd


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-30 14:37:25 評論於
Review speed: 2.0 | Submission success rate: 75.0 Focus on research area: Cardiovascular Experience sharing: Comparatively friendly, submission in January, revision in March, acceptance by the end of April
(0) 讚! | Cornelius Lynd

作者: 九阳平晓


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-10 17:08:04 評論於
Awesome!
(0) 讚! | 九阳平晓

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [Therapeutic Advances in Chronic Disease] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*